News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CLSA Drops BEONE MEDICINES (06160.HK) TP to $286.2 as 4Q25 NP Misses
BEONE MEDICINES (06160.HK)'s 4Q25 results were mixed, with sales increasing by 32.8% YoY, beating market consensus, according to CLSA's research report. However, net profit...
Reset
Send
The window will close in 5 seconds
<Research>CLSA Drops BEONE MEDICINES (06160.HK) TP to $286.2 as 4Q25 NP Misses
Close
Recommend
3
Positive
4
Negative
1
 
SHORT SELL
 
STOCK INFO

BEONE MEDICINES (06160.HK)  -3.400 (-1.906%)    Short selling $310.58M; Ratio 40.136%   's 4Q25 results were mixed, with sales increasing by 32.8% YoY, beating market consensus, according to CLSA's research report. However, net profit missed expectation due to an one-off impairment. Management guided for sales of US$6.2 billion to US$6.4 billion in 2026, representing a YoY growth of approx. 20%.

CLSA believed that the Company has multiple late-stage pipeline catalysts in the future, including BCL-2, BTK CDAC and CDK4. After factoring in the results, the broker chopped its target prices for BEONE MEDICINES' H-shares/ US stock/ A-shares from $288/ US$491.2/ RMB423.4 to $286.2/ US$485.1/ RMB384.5, with ratings kept at Outperform.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-03-04 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.